Key Events This Week
15 Jun: Stock opens at Rs.1,618.75, Sensex up 1.19%
16 Jun: New 52-week high at Rs.1,774.3; intraday high Rs.1,752.8; surge on high-value trading
17 Jun: Technical momentum shifts bullish; stock closes at Rs.1,650.50 (+0.61%)
19 Jun: Week closes at Rs.1,635.95 (-1.45%) amid profit-taking

Dr Lal Pathlabs Ltd Technical Momentum Shifts Signal Bullish Outlook
2026-06-17 08:05:36Dr Lal Pathlabs Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators that suggest a strengthening trend in the healthcare services sector. The stock’s recent upgrade from a Sell to a Hold rating reflects improved market sentiment and technical signals, positioning it as a stock to watch amid evolving market dynamics.
Read full news article
Dr Lal Pathlabs Ltd Surges on High-Value Trading and Institutional Interest
2026-06-16 11:00:10Dr Lal Pathlabs Ltd (LALPATHLAB) witnessed a remarkable surge in trading activity on 16 Jun 2026, emerging as one of the most actively traded stocks by value in the healthcare services sector. The stock soared to a new 52-week high of Rs 1,776, registering an impressive 11.16% gain on the day and outperforming its sector by over 9%. This rally reflects growing institutional interest and robust market participation despite a slight dip in delivery volumes, signalling a nuanced but positive outlook for this small-cap healthcare services company.
Read full news article
Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 1774.3
2026-06-16 10:44:17With a decisive surge to Rs 1774.3 on 16 Jun 2026, Dr Lal Pathlabs Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This rally has been underpinned by a confluence of bullish technical indicators and sustained outperformance against the broader market.
Read full news article
Dr Lal Pathlabs Ltd Surges 7.09% to Day's High of Rs 1752.8 — Outperforms Sector by 7.18 Percentage Points
2026-06-16 09:31:35The Sensex advanced 0.42% on 16 Jun 2026, yet Dr Lal Pathlabs Ltd outpaced the broader market with a 7.09% gain, touching an intraday high of Rs 1752.8. This 7.18 percentage-point outperformance over its Healthcare Services sector peers signals a distinctly stock-specific rally rather than a market-wide lift.
Read full news articleDr Lal Pathlabs Gains 4.20%: 3 Key Technical and Valuation Factors Driving the Move
2026-06-13 11:02:29
Key Events This Week
8 Jun: Stock opens at ₹1,545.55, Sensex down 1.33%
9 Jun: Stock gains 1.93% on strong volume, Sensex up 0.88%
11 Jun: Golden Cross formation signals bullish breakout
12 Jun: MarketsMOJO upgrades rating to Hold; stock closes at ₹1,600.50

Dr Lal Pathlabs Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Valuation
2026-06-12 08:14:24Dr Lal Pathlabs Ltd has seen its investment rating upgraded from Sell to Hold as of 11 June 2026, reflecting a notable improvement in technical indicators alongside steady financial metrics. The healthcare services company’s Mojo Score has risen to 58.0, signalling a more balanced outlook amid mixed growth and valuation factors.
Read full news article
Dr Lal Pathlabs Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook
2026-06-12 08:04:22Dr Lal Pathlabs Ltd has exhibited a notable shift in technical momentum, moving from a mildly bearish to a mildly bullish trend, supported by a combination of bullish signals across key indicators such as MACD, moving averages, and Bollinger Bands. Despite some mixed monthly signals, the stock’s recent price action and technical parameters suggest cautious optimism for investors in the healthcare services sector.
Read full news article
Golden Cross Confirmed: Do Dr Lal Pathlabs Ltd's Other Technical Indicators Agree?
2026-06-11 18:01:11The 50-day moving average has crossed above the 200-day moving average for Dr Lal Pathlabs Ltd, signalling a golden cross on 11 Jun 2026. Yet, the broader technical picture is nuanced, with weekly indicators mostly bullish but monthly momentum showing mild bearishness. This divergence raises the question of whether the golden cross stands as a reliable signal or is merely one piece of a more complex puzzle.
Read full news articleUpdate On Incorporation Of A Wholly Owned Subsidiary Company
12-Jun-2026 | Source : BSEAttached
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
13-May-2026 | Source : BSEAttached
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
06-May-2026 | Source : BSEAttached
Corporate Actions
No Upcoming Board Meetings
Dr Lal Pathlabs Ltd has declared 40% dividend, ex-date: 25 Jun 26
No Splits history available
Dr Lal Pathlabs Ltd has announced 1:1 bonus issue, ex-date: 19 Dec 25
No Rights history available






